Under The Spotlight: AbbVie
March 12, 2019 at 21:33 PM EDT
Long-term investors may want to inject AbbVie into their portfolio, a high-quality biotech firm with market-leading products, a growing new product pipeline, strong cash flows, substantial share repurchases and a healthy dividend.
